Dialysis device startup Advent Access soothes kidney patients' pain point
KIDNEY-failure patients undergoing hemodialysis suffer numerous needle insertions every week, with each prick running the risk of pain, ineffectiveness and wearing out the target vein.
Medical device startup Advent Access is going after that literal pain point, with the goal of ultimately making needling so easy that patients can do it by themselves. The company has a core product, av-Guardian, on the verge of obtaining CE market approval, and a recently acquired already-commercialised solution that could help to jumpstart growth.
"(Allowing patients to needle themselves) might sound like a good-to-have, but the significance of that is that it is the biggest bottleneck in freeing the patient from the nurse and the infrastructure," said Advent Access founder and chief executive Peh Ruey Feng.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Startups
High Court dismisses bid by co-founder and CTO to liquidate Cake Group
Semiconductor unicorn Silicon Box vows to avoid geopolitical mire
A cheat sheet of startup and tech M&As in South-east Asia
Zilingo ex-CEO’s criminal complaint is retaliation against whistleblowers: source
Gojek and ComfortDelGro Taxi to send untaken rides to each other’s platforms
SG fintech firm Bambu shuts down after missing profit targets, says founder